| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/20/2007 | US7179806 Δ1-pyrrolines used as pesticides |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/20/2007 | CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones |
| 02/15/2007 | WO2007018514A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/15/2007 | WO2007018508A1 Novel m3 muscarinic acetycholine receptor antagonists |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018193A1 Novel cercosporamide derivative |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017740A1 Salts and polymorphs of a vergf-r inhibitor |
| 02/15/2007 | WO2007017649A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 02/15/2007 | WO2007017289A2 Acyltryptophanols for fertility control |
| 02/15/2007 | WO2007017135A2 Process for the preparation of olmesartan medoxomil |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2006081337A3 Erastin analogues and their uses for killing cancer cells |
| 02/15/2007 | US20070037984 Biphenyl derivatives |
| 02/15/2007 | US20070037977 Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037975 Substituted-1,3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037852 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 02/15/2007 | US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 02/15/2007 | US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037801 Novel indoles are cannabinoid receptor ligands |
| 02/15/2007 | US20070037788 5-(3,8-Difluoro-6H-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-(1-ethyl-pyrrolidin-3-yl) -1,3-dihydro-benzoimidazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2618622A1 Novel cercosporamide derivative |
| 02/15/2007 | CA2618486A1 Ep2 receptor agonists |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2616466A1 Process for the preparation of olmesartan medoxomil |
| 02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | CA2615760A1 Salts and polymorphs of n,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide |
| 02/15/2007 | CA2605481A1 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
| 02/14/2007 | EP1751145A1 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
| 02/14/2007 | EP1751144A1 Constrained himbacine analogs as thrombin receptor antagonists |
| 02/14/2007 | EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751139A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 02/14/2007 | EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 02/14/2007 | EP1751127A2 Novel cylopenta¬b|benzofuran derivatives and the utilization thereof |
| 02/14/2007 | EP1751124A2 Raf modulators and methods of use |
| 02/14/2007 | EP1751115A1 Theramutein modulators |
| 02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1751105A1 Piperazine derivatives of alkyl oxindoles |
| 02/14/2007 | EP1751103A1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 02/14/2007 | EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 02/14/2007 | EP1751089A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1294715B1 Quinazoline ditosylate salt compounds |
| 02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914197A Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
| 02/14/2007 | CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 02/14/2007 | CN1914173A Quinolines useful in treating cardiovascular disease |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1911904A 2-substituted rubrene compound and its synthesis method and application |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/13/2007 | US7176326 β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes |
| 02/13/2007 | US7176317 Anthraquinone, xanthene dyes |
| 02/13/2007 | US7176316 Amino-piperidine derivatives |
| 02/13/2007 | US7176314 Inflammation modulators |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176236 Water-soluble etoposide analogs and methods of use thereof |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176211 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/13/2007 | US7176197 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/13/2007 | US7176161 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent |
| 02/13/2007 | US7175872 Food sweetness or saltiness enhancers; such as N(1-carboxyethyl)-6-hydroxymethyl-pyridinium-3-olate; synthesis from amino acid or peptide with furan derivative |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/08/2007 | WO2007016354A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |